Claudin association with CD81 defines hepatitis C virus entry.
about
Recent advances in understanding hepatitis CEntry inhibitors: New advances in HCV treatmentRoles of lipoprotein receptors in the entry of hepatitis C virusImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesThe hepatitis C virus glycan shield and evasion of the humoral immune responseInfection Counter: Automated Quantification of in Vitro Virus Replication by Fluorescence MicroscopyMathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entryA novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmissionRecent advances in hepatocellular carcinoma therapy.Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Hepatitis C virus induces CD81 and claudin-1 endocytosis.Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors.Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmissionProduction, purification and characterization of recombinant, full-length human claudin-1.The missing pieces of the HCV entry puzzle.Regulated Entry of Hepatitis C Virus into Hepatocytes.A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infectionA human claudin-1-derived peptide inhibits hepatitis C virus entry.HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.Species-specific regions of occludin required by hepatitis C virus for cell entry.Recent advances in human viruses imaging studies.Architecture of tight junctions and principles of molecular composition.Claudins and the modulation of tight junction permeability.Hepatitis C virus life cycle and lipid metabolismInteracting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infectionHepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics.Elucidating the principles of the molecular organization of heteropolymeric tight junction strands.Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.Hepatitis C virus is primed by CD81 protein for low pH-dependent fusionHepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyNovel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.Hepatitis C virus host cell entry.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.
P2860
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
P248
Q26766136-6239D272-ACFC-4A47-AB77-2619632BF1CCQ26770817-F61D2C2D-D718-4619-B0F0-A613AA37EBC0Q26777338-9142D2C7-27B0-4957-904D-AB4FF24E92A5Q26864485-EE6FA512-D1AF-4926-A2F2-14E85E2FFE58Q26992256-D43CA1F2-F273-466F-9C34-E0ACE830CAC2Q27023390-F7E68391-B8FE-4A82-BB22-40D921E76233Q28364857-4A6CDB01-9E91-43C8-A3A5-2310EA192303Q28478310-27494181-E83F-47D8-8DC3-FB531093E626Q28488372-45DA69AA-5680-4A54-975C-5EE1F8B630CEQ30236010-B8D25760-9328-4463-B9A6-59E5EFC916F9Q30364309-E27766E7-78CC-4492-82E5-D4EC97B1A615Q30386551-F9060E57-F18C-4532-AB4A-9F0F316DBAB9Q30512696-6450D4DD-71DE-4500-A297-B7601AB4E14DQ30541731-D0DE936C-266A-4D07-9CB0-3423A509FF37Q30541733-454E9621-2066-43EE-820A-7BF2A68FD347Q31118101-CB633ACD-3343-483E-90C3-4511F50749E2Q33360674-3E4A1ACF-ED67-427D-A0DC-48911A9A7D77Q33753913-D00BD81E-AEC3-4BF6-BFC6-C5D0DF4AE4C9Q34009510-A6758F65-E70A-4CB8-A1C4-F2174881E10BQ34179353-D6D0F0EE-732B-46D4-B030-B898097AB929Q34216377-70A63C89-B3B2-476C-B95D-366366425D1CQ34251341-0F27E837-0AD3-44BF-AA39-C540627832D5Q34296017-91D8C5C8-3D73-43D4-A5DD-60332B9E8587Q34521364-856B2CFE-78CA-4294-A4BC-F69AA63E12F0Q34624331-7DE113A9-F03A-42D9-B3C5-2D8C46668381Q34650517-B79226E6-3AD5-4F6F-9D89-6544F9B1EE73Q34792436-58F72200-26FD-4859-B4BB-9E32E329A6FCQ34799950-3D93A39A-0786-4169-BCA8-CE1F9CDDB05EQ34860505-023FFEF3-0489-449C-B25E-A39CE01471C7Q35107926-5910568C-6A9A-4199-A1E0-BEF88546DF45Q35125004-F7738016-D1F3-48B6-B014-957FF86FF957Q35182834-C29FC74C-DC45-4A13-AD9A-622D6AFBD861Q35213305-B97EB9D2-A227-4CD2-88B2-712AAD52D4D3Q35488854-54B48EB7-C06D-430B-B637-61CB9BD16B9BQ35602284-7313F1D9-9727-4447-9AD2-DBC28DB72042Q35828072-0B921097-C8F4-4C56-BD83-A235C807361EQ35839680-7CDFA3CC-03DA-4615-B4F5-A8E86FD3EB28Q35851742-6F73BF1D-80C4-45C5-A884-E5475FDD318CQ35914270-A1055C6C-16EE-4A35-8FBD-46639156F3CFQ35975438-6659572D-FCDD-4096-9B2A-8A5753CDF854
P2860
Claudin association with CD81 defines hepatitis C virus entry.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Claudin association with CD81 defines hepatitis C virus entry.
@ast
Claudin association with CD81 defines hepatitis C virus entry.
@en
type
label
Claudin association with CD81 defines hepatitis C virus entry.
@ast
Claudin association with CD81 defines hepatitis C virus entry.
@en
prefLabel
Claudin association with CD81 defines hepatitis C virus entry.
@ast
Claudin association with CD81 defines hepatitis C virus entry.
@en
P2093
P2860
P50
P921
P3181
P356
P1476
Claudin association with CD81 defines hepatitis C virus entry
@en
P2093
Christopher Davis
Helen J Harris
Margaret Goodall
Michelle J Farquhar
Stephen Young
P2860
P304
21092-21102
P3181
P356
10.1074/JBC.M110.104836
P407
P5008
P577
2010-04-07T00:00:00Z